Imexpharm Corporation announced that at the General Meeting of Shareholders held on December 19, 2023, approved election of Mr. Hoang Duc Hung as an independent member of the Board of Directors of the Company for the term 2023-2027. Year of birth: 1973, Literacy: Postgraduate. Professional level: Master of International Finance (Oxford Brookes), CIA (IIA), FCCA, FCPA Aust, VACPA.

Nationality: Vietnamese. Employment history: From 11/1994 to 06/2014: Audit Director, Leadership of Advisory Services Division, Leadership of the Government and Public Sector Clients Division, Ernst & Young (EY) Vietnam Limited. From 07/2014 to 09/2016: International Consultant - World Bank, supporting the Ministry of Finance in building the Internal audit framework in Vietnam.

From 10/2016 to 11/2020: Deputy General Director - PwC Vietnam Limited. From 12/2020 to present: Chairman of the BOD - of CGS Vietnam Governance Consultancy Joint Stock Company; Board Member - Gentis Testing Service Joint Stock Company. From 09/2022 to present: Vice President, Executive Committee Member of Vietnam Independent Directors Association; President of Institute of Internal Auditors Vietnam - IIA Vietnam Chapter.

Current positions at other Organizations: President of Institute of Internal Auditors Vietnam - IIA Vietnam Chapter. Vice President, Executive Committee Member of Vietnam Independent Directors Association. Chairman of CGS Vietnam Governance Consultancy Joint Stock Company.

Members of BOD of Gentis Testing Service Joint Stock Company. Independent BOD Member of No Va Land Investment Group Corporation.